Skip to main content
Clinical Trials/NCT03753568
NCT03753568UnknownNot Applicable

Effect of an Electronic Reminder System on Direct Oral Anticoagulant and Oral Diabetes Medication Adherence

Helsinki University Central Hospital1 site in 1 country100 target enrollmentStarted: March 20, 2019Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Enrollment
100
Locations
1
Primary Endpoint
Adherence to the medication

Study Overview

Brief Summary

In this study, the effect of an electronic device attached to a push through pill package and a smart phone application on chronic disease medication adherence is studied.

Detailed Description

In this study study two different groups of medicine users are recruited. Both groups have 50 patients each. In the first study the participants are using oral medication for diabetes and in the second study the participants use new direct oral anticoagulants.

Participants use medicine reminder system consisting of an electronic device and an smart phone application. In the beginning of the study the reminder system is collecting data on how the patients are taking their medication for the first two months. Smart phone application is not providing any reminders and participants can't access the app to see the details.

After two months the application will be unlocked so that it starts reminding the users to take their medication at the right time. in this phase the patients can view their medication data from the application. The reminder phase of the study lasts for two months. After these two plus two months, the results are analyzed and published.

The study continues after these four months for the next four months and after that, the long term results are analyzed.'

The primary outcome is the possible change in the adherence between control and active period.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •use of direct oral anticoagulants or oral diabetic drugs
  • •age of 18 or more
  • •subjects have been using a smart phone

Exclusion Criteria

  • •patients who don't use their medication without help

Arms & Interventions

Study group

Experimental

The participants use either direct oral anticoagulants or oral diabetic medication.

Intervention: Electronic medicine reminder system (Device)

Outcomes

Primary Outcomes

Adherence to the medication

Time Frame: 8 months

PDC - proportion of days covered

Secondary Outcomes

  • Variation of daily pill taking times(8 months)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Janne Sahlman

Chief medical officer, Popit Ltd

Helsinki University Central Hospital

Study Sites (1)

Loading locations...

Similar Trials

Effect of an Electronic Reminder System on... | Clinical Trial